Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05174949 · ClinicalTrials.gov registry record · NA
Targeted High-definition Transcranial Direct Current Stimulation (HD-tDCS) for Reducing Post-stroke Movement Impairments
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05174949 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 14 participants.
The verdict
NCT05174949, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Stroke is the leading cause of serious, long-term disability. The emergence of abnormal muscle synergies following a stroke presents a major limitation to the recovery of independent function. Despite the development of many interventions for movement recovery post-stroke, rehabilitation treatments are minimally effective to the muscle synergy impairment. Previous studies have found that muscle synergy impairment is associated with the damage to the corticospinal tract and the maladaptive recruitment of the contralesional cortico-reticulospinal tract. The investigators hypothesize that facilitating the damaged cortico-spinal tract (via primary motor cortex) and/or inhibiting the contralesional cortico-reticulospinal tract (via dorsal premotor cortex) will reduce muscle synergy impairment. In this pilot project, the investigators propose to run a proof-of-concept pilot trial to evaluate the effect of the targeted high-definition transcranial direct current stimulation (HD-tDCS) on mitigating muscle synergy impairment.
Interventions
- DEVICE Transcranial direct current stimulation (high-definition)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-01-18 |
| Est. Completion | 2023-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05174949
The ClinicalTrials.gov registry entry for NCT05174949 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial direct current stimulation (high-definition) is the first listed.
NCT05174949 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05174949 about?
NCT05174949 is a clinical study titled "Targeted High-definition Transcranial Direct Current Stimulation (HD-tDCS) for Reducing Post-stroke Movement Impairments". Stroke is the leading cause of serious, long-term disability. The emergence of abnormal muscle synergies following a stroke presents a major limitation to the recovery of independent function. Despite the development of many interventions for movement recovery post-stroke, rehabilitation treatments ...
What is the current status of trial NCT05174949?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-01-18. Estimated completion is 2023-05-12.
What interventions are being tested in trial NCT05174949?
The interventions under investigation include: Transcranial direct current stimulation (high-definition) (DEVICE).
Who is sponsoring clinical trial NCT05174949?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.